サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1790389

末梢動脈疾患の市場規模、シェア、動向分析レポート：機器タイプ別、解剖学的部位別、最終用途別、地域別、セグメント別予測、2025年～2033年

Peripheral Artery Disease Market Size, Share & Trends Analysis Report By Services (Endovascular Devices, Surgical Devices), By Anatomical Site (Aortoiliac, Femoropopliteal), By End-use, By Region, And Segment Forecasts, 2025 - 2033

出版日
ページ情報
英文 90 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.66円
末梢動脈疾患の市場規模、シェア、動向分析レポート：機器タイプ別、解剖学的部位別、最終用途別、地域別、セグメント別予測、2025年～2033年
出版日: 2025年07月08日
発行: Grand View Research
ページ情報: 英文 90 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

末梢動脈疾患市場の概要

世界の末梢動脈疾患市場規模は2024年に73億米ドルと推定され、2033年には113億米ドルに達すると予測され、2025～2033年のCAGRは5.2%で成長します。疾病負担の増加、継続的な技術進歩、人口動態の高齢化という交錯する力が末梢動脈疾患（PAD）産業を牽引しています。

満たされていない臨床ニーズと進化する治療能力が合致することで、医療現場全体の需要が加速します。糖尿病とタバコの有病率の増加は、依然として市場を牽引する基本的な力となっています。いずれの危険因子も、PADの中核的な病理学的メカニズムであるアテローム性動脈硬化症の進行に直接寄与しています。糖尿病の罹患率は世界的に上昇傾向にあり、特に都市部の高齢化社会では顕著で、低所得国では喫煙が依然として蔓延しているため、PADの罹患率は上昇を続けています。

2025年3月、ACC学会で発表されたIntermountain Healthの研究によると、症候性末梢動脈疾患を有する患者のうち、ガイドラインに沿った治療を受けたのは女性で29.6%、男性で33.5%に過ぎなかりました。追跡した7,522人の患者のうち、死亡率は50％を超えており、診断と治療における深刻なギャップが明らかになりました。同様の発表率にもかかわらず、女性は最適な治療を受ける可能性が低かりました。この研究では、スクリーニングプロトコルの改善とPAD管理の重点化の必要性が強調されました。

血管内治療技術の急速な革新は、治療戦略を再構築し、市場の勢いを強めています。薬剤コーティングバルーン、アテレクトミーシステム、生体吸収性ステントなどの次世代ツールは、有効性の向上、合併症の減少、回復時間の短縮をもたらします。これらのソリューションは、複雑な病変を正確に治療する一方で、再狭窄や再手術の必要性を低減するために、ますます支持されるようになっています。2025年3月、Scientific Reportsに掲載された研究では、血管内治療中のステント留置精度を向上させる深層学習モデルDBMedDetが発表されました。高精度（mAP 0.841）とリアルタイム検出（127 FPS）により、冠動脈、末梢、脳血管の各症例におけるステント境界の特定においてYOLOモデルを上回りました。

人口の高齢化はPADインターベンションの市場の可能性をさらに増幅させ、65歳以上の人は著しく高いリスクに直面しています。加齢に関連した動脈硬化と併存疾患の蓄積がこの人口層を特に脆弱にしています。2025年3月、エイジング・ジャーナル誌は、長寿家系の人はPADのリスクが有意に低いことを示すLong Life Family Studyの結果を発表しました。これらの家系の子孫におけるPAD有病率は、予想される12％に対してわずか1％でした。調査チームは、この結果を保護的遺伝形質とより健康的な血管プロファイルに結びつけ、PAD抵抗性に関連する可能性のある4つのゲノム領域を特定しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 世界の末梢動脈疾患市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 関連/付随市場の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 末梢動脈疾患市場分析ツール
    • 産業分析-ポーターのファイブフォース分析
    • PESTEL分析

第4章 末梢動脈疾患市場：機器タイプ別、推定・動向分析

  • 末梢動脈疾患市場：機器タイプダッシュボード
  • 末梢動脈疾患市場：機器タイプの変動分析
  • 末梢動脈疾患市場規模・予測・動向分析（機器タイプ別、2021～2033年）
  • 血管内機器
  • 外科用機器

第5章 末梢動脈疾患市場：解剖学的部位別、推定・動向分析

  • 末梢動脈疾患市場：解剖学的部位ダッシュボード
  • 末梢動脈疾患市場：解剖学的部位変動分析
  • 末梢動脈疾患市場規模・予測・動向分析（解剖学的部位別、2021～2033年）
  • 大動脈腸骨
  • 大腿膝窩筋
  • 脛骨

第6章 末梢動脈疾患市場：最終用途別、推定・動向分析

  • 末梢動脈疾患市場：最終用途ダッシュボード
  • 末梢動脈疾患市場：最終用途変動分析
  • 末梢動脈疾患市場規模・予測・動向分析（最終用途別、2021～2033年）
  • 病院
  • 外来施設
  • その他

第7章 末梢動脈疾患市場：国、機器タイプ、解剖学的部位、最終用途による地域別、推定・動向分析

  • 世界の末梢動脈疾患市場：地域別ダッシュボード
  • 市場規模と予測動向分析、2021～2033年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 主要メーカーによる最近の動向と影響分析
  • 企業/競合の分類
  • ベンダー情勢
    • 主要販売代理店とチャネルパートナー一覧
    • 主要企業の市場シェア分析、2024年
    • BD
    • Bentley InnoMed
    • Scitech Medical
    • Abbott Laboratories
    • Boston Scientific Corporation
    • WL Gore & Associates, Inc.
    • Medtronic
    • Cook
    • Terumo Corporation
    • iVascular
    • Getinge AB
    • BIoTronik SE & Co KG
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 Global peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 4 Global peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million
  • Table 5 Global peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 6 Global peripheral artery disease market, by region, 2021 - 2033 (USD Million)
  • Table 7 North America peripheral artery disease market, by country, 2021 - 2033 (USD Million)
  • Table 8 North America peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 9 North America peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 10 North America peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 11 U.S. peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 12 U.S. peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 13 U.S. peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 14 Canada peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 15 Canada peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 16 Canada peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 17 Mexico peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 18 Mexico peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 19 Mexico peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 20 Europe peripheral artery disease market, by country, 2021 - 2033 (USD Million)
  • Table 21 Europe peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 22 Europe peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 23 Europe peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 24 UK peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 25 UK peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 26 UK peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 27 Germany peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 28 Germany peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 29 Germany peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 30 France peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 31 France peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 32 France peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 33 Italy peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 34 Italy peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 35 Italy peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 36 Spain peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 37 Spain peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 38 Spain peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 39 Denmark peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 40 Denmark peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 41 Denmark peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 42 Sweden peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 43 Sweden peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 44 Sweden peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 45 Norway peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 46 Norway peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 47 Norway peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific peripheral artery disease market, by country, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 51 Asia Pacific peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 52 Japan peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 53 Japan peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 54 Japan peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 55 China peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 56 China peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 57 China peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 58 India peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 59 India peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 60 India peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 61 Australia peripheral artery disease market, by country, 2021 - 2033 (USD Million)
  • Table 62 Australia peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 63 Australia peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 64 Australia peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 65 Thailand peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 66 Thailand peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 67 Thailand peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 68 South Korea peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 69 South Korea peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 70 South Korea peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 71 Latin America peripheral artery disease market, by country, 2021 - 2033 (USD Million)
  • Table 72 Latin America peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 73 Latin America peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 74 Latin America peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 75 Brazil peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 76 Brazil peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 77 Brazil peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 78 Argentina peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 79 Argentina peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 80 Argentina peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 81 MEA peripheral artery disease market, by country, 2021 - 2033 (USD Million)
  • Table 82 MEA peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 83 MEA peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 84 MEA peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 85 South Africa peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 86 South Africa peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 87 South Africa peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 89 Saudi Arabia peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 90 Saudi Arabia peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 91 UAE peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 92 UAE peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 93 UAE peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 94 Kuwait peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 95 Kuwait peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 96 Kuwait peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 97 Participant's overview
  • Table 98 Financial performance
  • Table 99 Key companies undergoing expansions
  • Table 100 Key companies undergoing acquisitions
  • Table 101 Key companies undergoing collaborations
  • Table 102 Key companies launching new products
  • Table 103 Key companies undergoing partnerships
  • Table 104 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Peripheral artery disease market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Peripheral artery disease market revenues, 2024 (USD Millions)
  • Fig. 9 Market driver relevance analysis (Current & future impact)
  • Fig. 10 Market restraint relevance analysis (Current & future impact)
  • Fig. 11 Porter's five forces analysis
  • Fig. 12 PESTLE analysis
  • Fig. 13 Peripheral artery disease market Device type outlook:
  • Fig. 14 Peripheral artery disease market: Device type movement analysis
  • Fig. 15 Segment dashboard
  • Fig. 16 Global endovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 17 Global surgical devices market, 2021 - 2033 (USD Million)
  • Fig. 18 Peripheral artery disease market Anatomical site outlook:
  • Fig. 19 Peripheral artery disease market: Anatomical site movement analysis
  • Fig. 20 Global aortoiliac market, 2021 - 2033 (USD Million)
  • Fig. 21 Global femoropopliteal market, 2021 - 2033 (USD Million)
  • Fig. 22 Global tibial market, 2021 - 2033 (USD Million)
  • Fig. 23 Peripheral artery disease market end use outlook:
  • Fig. 24 Peripheral artery disease market: end use movement analysis
  • Fig. 25 Global hospitals market, 2021 - 2033 (USD Million)
  • Fig. 26 Global outpatient facilities market, 2021 - 2033 (USD Million)
  • Fig. 27 Global others market, 2021 - 2033 (USD Million)
  • Fig. 28 Regional marketplace: Key takeaways
  • Fig. 29 North America peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 30 U.S. peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 31 Canada peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 32 Mexico peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 33 Europe peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 34 Germany peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 35 UK peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 36 France peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 37 Italy peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 38 Spain peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 39 Sweden peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 40 Denmark peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 41 Norway peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 42 Asia Pacific peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 43 Japan peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 44 China peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 45 India peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 46 Australia peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 47 Thailand peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 48 South Korea peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 49 Latin America peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 50 Brazil peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 51 Argentina peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 52 MEA peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 53 South Africa peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 54 Saudi Arabia peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 55 UAE peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 56 Kuwait peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 57 Market Participant Categorization
  • Fig. 58 Strategy mapping
目次
Product Code: GVR-4-68040-660-5

Peripheral Artery Disease Market Summary

The global peripheral artery disease market size was estimated at USD 7.3 billion in 2024 and is projected to reach USD 11.3 billion by 2033, growing at a CAGR of 5.2% from 2025 to 2033. The intersecting forces of rising disease burden, continuous technological advancement, and demographic aging drive the peripheral artery disease (PAD) industry.

This alignment of unmet clinical needs with evolving therapeutic capabilities accelerates demand across care settings. The growing prevalence of diabetes and tobacco use remains a foundational force driving the market. Both risk factors contribute directly to the progression of atherosclerosis, the core pathological mechanism behind PAD. With diabetes rates climbing globally-particularly in aging, urban populations-and smoking still widespread in lower-income countries, the incidence of PAD continues to rise.

In March 2025, an Intermountain Health study presented at the ACC conference revealed that only 29.6% of women and 33.5% of men with symptomatic peripheral artery disease received full guideline-directed therapy. Among 7,522 patients tracked, the mortality rate exceeded 50%, underscoring severe gaps in diagnosis and treatment. Despite similar referral rates, women were less likely to receive optimal care. The study emphasized the need for improved screening protocols and focused PAD management.

Rapid innovation in endovascular technologies is reshaping treatment strategies and reinforcing market momentum. Next-generation tools such as drug-coated balloons, atherectomy systems, and bioresorbable stents offer improved efficacy, fewer complications, and shorter recovery times. These solutions are increasingly favored for treating complex lesions precisely while reducing restenosis and the need for repeat interventions. In March 2025, a study in Scientific Reports introduced DBMedDet, a deep-learning model that improved stent placement accuracy during endovascular procedures. With high precision (mAP 0.841) and real-time detection (127 FPS), it outperformed YOLO models in identifying stent boundaries across coronary, peripheral, and cerebrovascular cases.

Population aging further amplifies the market potential for PAD interventions, with individuals over 65 facing significantly elevated risk. Age-related arterial stiffening and the accumulation of comorbidities make this demographic especially vulnerable. In March 2025, the Aging Journal published findings from the Long Life Family Study showing individuals from long-lived families have a significantly lower risk of PAD. PAD prevalence among offspring of these families was only 1%, versus an expected 12%. Researchers linked this to protective genetic traits and healthier vascular profiles, identifying four genomic regions potentially tied to PAD resistance.

Global Peripheral Artery Disease Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global peripheral artery disease market report based on device type, anatomical site, end use, and region:

  • Device Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Endovascular Devices
  • Surgical Devices
  • Anatomical Site Outlook (Revenue, USD Million, 2021 - 2033)
  • Aortoiliac
  • Femoropopliteal
  • Tibial
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Outpatient Facilities
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Device Type
    • 1.2.2. Anatomical Site
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecast timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity price analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Device Type Segment
    • 2.2.2. Anatomical Site Segment
    • 2.2.3. End Use Segment
    • 2.2.4. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Peripheral Artery Disease Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of diabetes and smoking
      • 3.2.1.2. Advancements in endovascular technologies
      • 3.2.1.3. Growing elderly population and PAD risk
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of advanced revascularization procedures
      • 3.2.2.2. Limited access to PAD treatment in low-income regions
  • 3.3. Peripheral Artery Disease Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Peripheral Artery Disease Market: Device Type Estimates & Trend Analysis

  • 4.1. Peripheral Artery Disease Market: Device Type Dashboard
  • 4.2. Peripheral Artery Disease Market: Device Type Movement Analysis
  • 4.3. Peripheral Artery Disease Market Size & Forecasts and Trend Analysis, by Device Type, 2021 - 2033 (USD Million)
  • 4.4. Endovascular Devices
    • 4.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 4.5. Surgical Devices
    • 4.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 5. Peripheral Artery Disease Market: Anatomical Site Estimates & Trend Analysis

  • 5.1. Peripheral Artery Disease Market: Anatomical Site Dashboard
  • 5.2. Peripheral Artery Disease Market: Anatomical Site Movement Analysis
  • 5.3. Peripheral Artery Disease Market Size & Forecasts and Trend Analysis, by Anatomical Site, 2021 - 2033 (USD Million)
  • 5.4. Aortoiliac
    • 5.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 5.5. Femoropopliteal
    • 5.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 5.6. Tibial
    • 5.6.1. Market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 6. Peripheral Artery Disease Market: End Use Estimates & Trend Analysis

  • 6.1. Peripheral Artery Disease Market: End Use Dashboard
  • 6.2. Peripheral Artery Disease Market: End Use Movement Analysis
  • 6.3. Peripheral Artery Disease Market Size & Forecasts and Trend Analysis, by End Use, 2021 - 2033 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.5. Outpatient Facilities
    • 6.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 7. Peripheral Artery Disease Market: Regional Estimates & Trend Analysis by Country, Device Type, Anatomical Site & End Use

  • 7.1. Global Peripheral Artery Disease Market: Regional Dashboard
  • 7.2. Market Size & Forecasts Trend Analysis, 2021 - 2033
  • 7.3. North America
    • 7.3.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. U.S. market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Canada market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key country dynamics
      • 7.3.4.2. Regulatory framework/ reimbursement structure
      • 7.3.4.3. Competitive scenario
      • 7.3.4.4. Mexico market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. UK market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Germany market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. France market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Italy market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Spain market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.4.8. Norway
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Norway market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.4.9. Denmark
      • 7.4.9.1. Key country dynamics
      • 7.4.9.2. Regulatory framework/ reimbursement structure
      • 7.4.9.3. Competitive scenario
      • 7.4.9.4. Denmark market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.5.3. Japan
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Japan market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. India market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Australia market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.5.7. South Korea
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework/ reimbursement structure
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. South Korea market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Brazil market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. Argentina market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.7. MEA
    • 7.7.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.7.3. South Africa
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. South Africa market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. UAE market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/ reimbursement structure
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. Kuwait market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2024
    • 8.3.4. BD
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Bentley InnoMed
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Scitech Medical
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Abbott Laboratories
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Boston Scientific Corporation
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. W. L. Gore & Associates, Inc.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Medtronic
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Cook
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Terumo Corporation
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. iVascular
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. Getinge AB
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Product benchmarking
      • 8.3.14.4. Strategic initiatives
    • 8.3.15. Biotronik SE & Co KG
      • 8.3.15.1. Company overview
      • 8.3.15.2. Financial performance
      • 8.3.15.3. Product benchmarking
      • 8.3.15.4. Strategic initiatives